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Abstract
Many protein engineering problems involve finding mutations that produce proteins with a particular function.
Computational active learning is an attractive approach to discover desired biological activities. Traditional active learning
techniques have been optimized to iteratively improve classifier accuracy, not to quickly discover biologically significant
results. We report here a novel active learning technique, Most Informative Positive (MIP), which is tailored to biological
problems because it seeks novel and informative positive results. MIP active learning differs from traditional active learning
methods in two ways: (1) it preferentially seeks Positive (functionally active) examples; and (2) it may be effectively extended
to select gene regions suitable for high throughput combinatorial mutagenesis. We applied MIP to discover mutations in
the tumor suppressor protein p53 that reactivate mutated p53 found in human cancers. This is an important biomedical
goal because p53 mutants have been implicated in half of all human cancers, and restoring active p53 in tumors leads to
tumor regression. MIP found Positive (cancer rescue) p53 mutants in silico using 33% fewer experiments than traditional
non-MIP active learning, with only a minor decrease in classifier accuracy. Applying MIP to in vivo experimentation yielded
immediate Positive results. Ten different p53 mutations found in human cancers were paired in silico with all possible single
amino acid rescue mutations, from which MIP was used to select a Positive Region predicted to be enriched for p53 cancer
rescue mutants. In vivo assays showed that the predicted Positive Region: (1) had significantly more (p,0.01) new strong
cancer rescue mutants than control regions (Negative, and non-MIP active learning); (2) had slightly more new strong cancer
rescue mutants than an Expert region selected for purely biological considerations; and (3) rescued for the first time the
previously unrescuable p53 cancer mutant P152L.
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Introduction
Engineering existing proteins to change their properties [1,2] is
an important task with many applications as diverse as environ-
mental protection, synthetic biomaterials, and pharmacology [3–8].
Here we apply machine learning techniques to engineer the tumor
suppressor protein p53. We choose where to mutate cancerous p53
to restore tumor suppressor function, using structure-based features
derived from in silico protein homology models.
Biology of p53 Cancer Rescue Mutants
The p53 gene encodes a tumor suppressor protein that is a key
cellular defense against cancer. p53 mutations occur in about 50%
of human cancers. The vast majority of these mutations are single
point missense mutations in the p53 core domain [9–12]. Thus,
many human cancers express full-length p53 cancer mutants that
lack tumor suppressor function. As demonstrated in vivo, p53 cancer
mutants can be reactivated through intragenic second-site suppres-
sor (‘‘cancer rescue’’) mutations [13–15]. Reactivated p53 holds
great therapeutic promise because animal models have shown that
reintroduction of active p53, even in advanced tumors, leads to
tumor regression [16–18]. Consequently, there have been many
efforts to find small molecule drugs that mimic the cancer rescue
effect of reactivating p53 and suppressing tumor growth [19–24].
Despite some promising discoveries in p53 in specific, and small
molecule dockingin general, these efforts arehampered by a limited
understanding of the p53 mutation-structure-function relationship
[11,25–28]. A larger and more diverse collection of cancer rescue
mutations that reactivate p53 cancer mutants is therefore desired.
Such a collection could lead to insight into general structural
changes that can rescue p53 cancer mutants, and thereby facilitate
rational drug design approaches by exploiting similar effects.
Several p53 cancer rescue mutants were identified previously by
random mutagenesis in a region spanning amino acid residues 225–
241. A portion of this region (235,239, and 240) thus was empirically
identified as a ‘‘Global Suppressor Motif’’, the first p53 cancer rescue
region [13]. The biological goal of this paper is to use computational
techniques to discover novel p53 cancer rescue mutants and regions.
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The active learning paradigm was developed in the machine
learning community to reduce the number of expensive examples that
need to be acquired to build an accurate classifier [29]. Active learning
typically starts with a small initial amount of labeled data. The initial
data is used to determine a small informative set of unlabeled
examples to label. Once labeled, these new examples are added to the
pool of labeled data and a new unlabeled set is chosen. The process
repeatedly labels new data until the classifier reaches some pre-
determined criteria. Active learning methods increase the efficiency
and cost effectiveness of the process by reducing the number of
examples that need to be labeled. The active learning paradigm is
readily applicable to biological experimentation, as it reduces the
number of tedious and expensive experiments to be performed.
In a biological active learning paradigm, a computational
classifier is trained with an initial set of examples labeled by direct
experimentation. In the case of p53 cancer rescue mutants [4], this
initial set consists of empirically labeled p53 mutants. The
computational classifier then predicts which mutants should next
be labeled to most improve the classifier accuracy. These mutants
are then made, labeled by biological assays, and added to the
classifier. The cycle repeats, iteratively improving classifier
accuracy and adding to the set of p53 mutants with known
function. In this way, an optimum active learning classifier would
adequately explore a mutant sequence space while using a
minimum amount of expensive biological experimentation [4].
It is important to note that in the context of biological
experimentation, the slowest part of active learning is generally the
biological experiments required to label the unknown examples.
Therefore, any reference to speed in this paper refers to the
number of expensive biological experiments (i.e. iterations of the
active learning cycle) and not to computational speed. The
computational goal of this paper is to provide and test
computational methods that can discover gene regions wherein
mutations produce proteins with a desired function, while
requiring as few experiments as possible.
Traditional Active Learning
Here we present a formal description of the active learning
problem. Notation is summarized in Text S1.
Let T be the Total set of all examples under consideration. Each
example mutant, m, has a labeling function, A, such that
Am ðÞ =Positive, Negative, or Unknown. During each active
learning iteration, i, T is partitioned into two groups: (1) TK,i,
examples with Known labels (i.e., Am ðÞ =Positive or Negative);
and (2) TU,i, examples with Unknown labels (i.e., Am ðÞ =Unknown).
A third set, TC,i,C h o s e nf r o mTU,i,c o n t a i n sn examples to be tested
and labeled in this step.
During each iteration the classifier provides a decision function,
hm ðÞ , trained on the examples with a known label, TK,i. Each
unlabeled example m is predicted by the decision function hm ðÞ to
be Positive or Negative.
A score function, score m ðÞ , ranks each example in TU,i.A sa
control, Random active learning assigns each mutant a random
score. The n highest ranked examples become TC,i and are then
tested and labeled. TC,i is merged with TK,i to create TK,iz1 and
deleted from TU,i to create TU,iz1.
In the case of the p53 cancer rescue mutants here, each example
mis a p53 mutant. Am ðÞ =Positive if and only if mutant mexhibits
wild-type like p53 transcription activator activity.
Structure of this Paper
The Methods section presents a description of active learning,
the MIP paradigm, computational evaluation methods, and
the biological experimental design. The Results section shows
in silico results indicating the computational techniques best
suited to the p53 cancer rescue mutant problem and in vivo
results showing how well those techniques performed in
experiments. The Discussion section recites medical signifi-
cance, sketches possible computational extensions of the MIP
method, and concludes that a computational classifier and
modeled structure-based features can guide function-based
experimental discovery.
Methods
Active learning refers to a body of iterative machine learning
techniques designed to train an accurate classifier using the
minimum number of expensive examples [29–32]. The Most
Informative Positive (MIP) method, introduced here, preferentially
selects examples (i.e., p53 mutants) predicted to be both
informative and Positive. The MIP computational method can
be used to modify any active learning method that does not
consider predicted class as a criterion for choosing which
expensive examples to learn. Here, MIP modified the active
learning algorithms described in [4] and was used to select regions
in the p53 tumor suppressor protein.
This section contains:
(1) An introduction to structure-based features and active
learning.
(2) A description of the MIP active learning method.
(3) Metrics for evaluating how quickly an active learning
algorithm uncovers Positive mutants.
(4) The data sets used for in silico evaluation.
(5) The general Regional Selection algorithm.
(6) Regional Selection as implemented for the p53 cancer rescue
problem.
(7) A brief overview of the biological techniques used to test the
mutant regions.
Foundations: Structure-Based Features and Active
Learning
The techniques presented in this paper build on previous
research using machine learning techniques to find p53 cancer
Author Summary
Engineering proteins to acquire or enhance a particular
useful function is at the core of many biomedical
problems. This paper presents Most Informative Positive
(MIP) active learning, a novel integrated computational/
biological approach designed to help guide biological
discovery of novel and informative positive mutants. A
classifier, together with modeled structure-based features,
helps guide biological experiments and so accelerates
protein engineering studies. MIP reduces the number of
expensive biological experiments needed to achieve novel
and informative positive results. We used the MIP method
to discover novel p53 cancer rescue mutants. p53 is a
tumor suppressor protein, and destructive p53 mutations
have been implicated in half of all human cancers. Second-
site cancer rescue mutations restore p53 activity and
eventually may facilitate rational design of better cancer
drugs. This paper shows that, even in the first round of in
vivo experiments, MIP significantly increased the discovery
rate of novel and informative positive mutants.
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foundational structure-based features and active learning tech-
niques.
Structure-based features [3,4] for each mutant considered were
extracted from atomic-level homology models. Modeled mutant
proteins were produced in silico using the B chain of the wildtype
p53 core domain crystal structure (PDB ID: 1TSR) [33]. Amino
acids were substituted and model energies were minimized using
the Amber
TM molecular modeling software [34]. Features [3]
were extracted from the minimized mutant model using 1D
sequence and amino acid substitution information, 2D surface
cartographical and electrostatic models, 3D steric analysis, and
‘‘4D’’ thermal stability predictions. Those features on the surface
of the p53 core domain outside known binding sites [35] were
compressed, resulting in 5,867 features per mutant. Conditional
Mutual Information Maximization [36] selected various subsets of
these features. It was found that 550 selected features resulted in
the highest classifier accuracy [4].
Seven previously studied [4] active learning algorithms were
used here. Two of these methods are standard active learning
techniques, taken from the literature, that work by separating the
data into two classes with an n-dimensional hyper-plane.
Minimum Marginal Hyperplane [37] selects examples based
on the margin, i.e., the ‘‘distance’’ from the hyper-plane.
Maximum Entropy [38] selects examples based on a class
probability calculated from the margin and is related to the
information theory concept of entropy. Two methods, Maxi-
mum MarginalHyperplaneand MinimumEntropy,are negative
controls expected to perform badly. They were created by
choosing the least informative example in the previous two
methods. The other three methods were created specifically for
this p53 cancer rescue research project [4] and are based on the
anticipated change in classifier accuracy or correlation coeffi-
cient if a given example is chosen and labeled. These include
Additive/Maximum Curiosity [4], which uses a cross-validated
correlation coefficient to estimate classifier accuracy, and
Additive Bayesian Surprise, which is based on the Kullback-
Leibler (KL) divergence [39].
MIP Methodology
MIP optimizes the mutants chosen so that they are most likely
to both improve the classifier and rapidly uncover Positive
examples. To understand why this is important, suppose that
Positive examples are sparse, as here, and one has only sufficient
resources to assay 100 new examples. MIP active learning seeks to
maximize the number of novel Positive examples discovered
during those 100 assays, and at the same time quickly improve
classifier accuracy. Traditional active learning also seeks to find an
accurate classifier quickly, but may discover only very few novel
Positives while so doing.
MIP active learning chooses TC,i by first considering only those
unlabeled examples predicted to be Positive (i.e., hm ðÞ =Positive).
Those predicted to be Positive and having the highest score,
score m ðÞ , are chosen for TC,i. Only if too few examples in TU,i
were predicted to be Positive would a Negative informative
example be chosen for TC,i.
Active learning algorithms may become MIP algorithms by
preferentially labeling those informative examples that are also
predicted to be Positive. There are many ways to apply MIP to a
specific active learning algorithm. Here we give a simple exam-
ple, which shows a general approach and applies to nearly all
active learning algorithms. Recall that score m ðÞ ranks unlabeled
examples, and high-ranking examples are chosen to be labeled at
the next iteration. To convert a traditional active learning
algorithm to a MIP active learning algorithm, it is sufficient to
weight the scoring function so that examples predicted to be
Positive have a higher score than those predicted to be Negative:
scoreMIP m ðÞ ~score m ðÞ zw ð1Þ
where w i sac o n s t a n tw i t hwwmaxx score x ðÞ ðÞ if hm ðÞ =Positive,
and w~0 if hm ðÞ =Negative.
Metrics: Halfway Point, Accuracy, Correlation Coefficient
For this paper and much biological research, the goal of
iterative exploration is to uncover as many informative Positive
examples as quickly as possible, i.e., with the fewest biological
experiments. We require metrics to measure success at this task.
The Halfway Point metric measures the fraction of iterations
necessary before half of all Positive examples in an unlabeled data
set are uncovered. Several additional metrics were explored to
measure how quickly Positive examples were found, including
enrichment factor and positive area, but only Halfway Point is
presented here for illustrative clarity because it is simple to explain
and it provides similar results to the other metrics.
Formally, Halfway Point= j   n ðÞ =jTU,1j, where j is the smallest
number of iterations such that TK,jz1 contains half of all Positive
mutants in TU,1 and n~jTC,1j is the number of mutants labeled at
each iteration.
Since MIP optimizes a classifier to preferentially choose
Positive mutants for TC,i, it is reasonable to wonder if there may
be a corresponding loss of classifier accuracy. One way to
estimate classifier accuracy for an active learning algorithm is to
use the average 10-fold cross-validated accuracy and correla-
tion coefficient of the training set TK,i across all iterations of one
or more of the Data Partitions described below. Accuracy is the
fraction of correct predictions. The correlation coefficient is a
standard of the machine learning community [40], and a better
measure than accuracy when the data set contains unbalanced
numbers of Positive and Negative examples. This is the usual
case for biological data sets such as the p53 cancer rescue
mutant data set, where the ratio of Negative to Positive mutants
is about 4:1.
Several other metrics for accuracy were explored, including
forward prediction accuracy, 3-point accuracy, and a more
complicated cross-validation strategy, OECV [4]. Average 10-fold
cross-validated accuracy and correlation coefficient were chosen
for illustrative clarity here because they are simple to explain and
give similar results to the other metrics.
Evaluation In Silico
To evaluate the MIP methodology in silico, MIP and non-MIP
versions of seven active learning methods plus a random control
were compared using the cross-validated metrics described above.
Three previously studied partitions of the data set [4] were used to
compare to previous research. These partitions test three common
starting conditions for active learning:
(1) Data Partition 1: Few mutants in TK,1 and many in TU,1, i.e.,
jTK,1j=25 and jTU,1j=236.
(2) Data Partition 2: Similar numbers of mutants in TK,1 and
TU,1, i.e., jTK,1j=123 and jTU,1j=138.
(3) Data Partition 3: Many mutants in TK,1 and few in TU,1, i.e.,
jTK,1j=204 and jTU,1j=57.
The data set had about 20% Positive and 80% Negative
mutants.
Predicting Positive p53 Cancer Rescue Regions
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Active learning and MIP as discussed so far apply to individual
mutants. Limitations of this approach include loss of classifier
accuracy when applied to new mutants from unfamiliar regions,
leading to many experiments that yielded few Positive examples
[4]. We generalized MIP active learning to apply to single amino
acid changes in contiguous gene regions. This generalization
supported several desirable outcomes. It allowed MIP active
learning to exploit high throughput saturation mutagenesis
techniques. The resulting training set enrichment should allow
more accurate prediction of new Positive mutants, especially those
requiring multiple amino acid changes. Regions enriched for
rescue mutants may indicate promising candidate drug target sites.
Formally, let Ma be the set of all mutants containing a cancer
mutation plus a single putative rescue at amino acid location a,
excluding mutants that exist in the initial training set TK,1. Let
Positive Meana~
X
m[Positivea
score m ðÞ
jPositiveaj
ð2Þ
where Positivea is the subset of Ma for which hm ðÞ =Positive.
Positive regions were ranked by summing PositiveMeana across
each region. The Positive Region used below was chosen to be the
10 sequential amino acid long window with the highest average
PositiveMeana across that window.
Similarly, let
NegativeMeana~
X
m[Negativea
score m ðÞ
jNegativeaj
ð3Þ
where Negativea is the subset of Ma for which hm ðÞ =Negative.
The Negative Region was chosen to be the 10 sequential amino
acid long window with the highest average NegativeMeana across
that window.
A similar non-MIP control region was constructed to be
informative to the classifier regardless of whether mutants were
predicted to be Positive or Negative. Let
Meana~
X
m[Ma
score m ðÞ
jMaj
ð4Þ
The non-MIP Region was chosen to be the 10 sequential amino
acid long window with the highest average Meana across that
window.
Regional Selection Implementation
To detect p53 cancer rescue regions, the task is to identify areas
of the p53 core domain that are likely to have many Positive
cancer rescue mutants. We considered ten p53 cancer mutants
that are commonly found in human cancer [12] and can be
constructed so that they differ by two or more nucleic acid changes
from the wild-type. Ma consisted of these 10 common p53 cancer
mutants paired with all possible single amino acid changes at each
location in the core domain. All predictions and curiosity
calculations were made with a training set, TK,1, of 463 mutants
(91 Positive and 372 Negative). These 463 mutants contained the
261 mutants used for the Data Partitions plus 202 created during
other experiments using variants of the yeast assay described below
[3,4,13,14].
The MIP Additive Curiosity [4] algorithm was used to choose
the regions because it performed best in in silico trials (see Results).
It was adapted to select three 10-amino acid long regions in the
p53 core domain: a Positive region, a Negative region, and a non-
MIP control region. A Weka Support Vector Machine, SMO,
[41], was used to predict the activity, hm ðÞ , for each mutant. The
score for each mutant was calculated using MIP Additive
Curiosity. These values were averaged over every possible 10-
amino acid window. The classifier considered the resulting 34,776
putative cancer rescue mutants and selected ,3,980 mutants in
three regions. These regions were selected for the following criteria
as described above:
(1) Positive Region: predicted to be informative and contain
novel Positive mutants.
(2) Negative Region: a control predicted to be informative and
contain few Positive mutants.
(3) non-MIP Region: a control predicted to be informative
regardless of mutant activity.
As another control, these regions were compared to:
(4) Expert Region: a control selected for biological considerations
by an expert p53 cancer rescue biologist and hypothesized to
contain Positive cancer rescue mutants.
The Expert Region, spanning residues 114–123, was considered
a potential cancer rescue region because several Positive muta-
tions with multiple amino acid changes occurred there spontane-
ously in previous cancer rescue mutant screens. Therefore, this
region was considered likely to have cancer rescue mutants with
single amino acid changes ([13]; Brachmann, R. K., personal
communication).
No single amino acid change cancer rescue mutations had been
found previously in any of the Positive, Negative, non-MIP, or
Expert regions.
Regional Saturation Mutagenesis and Yeast Assay
All mutants produced in this study were initially created with
a novel regional saturation mutagenesis method based on the
Quick Change site-directed mutagenesis kit (Stratagene, La
Jolla, CA, USA), (manuscript in preparation). Briefly, a set
of overlapping degenerate oligonucleotides was designed such
that each primer contained exactly one random codon. A
standard site-directed mutagenesis reaction was performed
with a mixture of oligonucleotides that collectively represented
each possible codon change in the target region (30 base pairs).
The overlapping primer design prevented multiple mutations
in the same mutagenesis product. The generated mutants were
analyzed for p53 activity using a yeast-based p53 activity
assay [13].
Briefly, yeast cells were engineered to depend on active p53 for
expression of the URA3 gene. The URA3 gene product is required
for the synthesis of uracil. When cells are grown in medium lacking
uracil, cell growth is proportional to p53 activity (URA3
expression). The products of the saturation mutagenesis for all
ten p53 cancer mutants in all tested regions were first selected for
their ability to grow in the absence of uracil, indicating re-
activated p53. All putative positive mutants were analyzed by
DNA sequencing to determine the nature of the rescue mutation.
Mutations were then recreated by site-directed mutagenesis,
confirmed by resequencing, and retested.
As shown in Figure 1, mutants were designated as strong
Positive mutants if the yeast cell growth was very robust.
Mutants contained in yeasts that showed minimal growth were
designated as weak Positive mutants. Strong and weak Positive
mutants were collectively designated Positive. Those that did
not grow were designated Negative. p53 mutants are described
Predicting Positive p53 Cancer Rescue Regions
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example, P152L_q100i identifies a cancer mutation with
leucine replacing proline at amino acid 152 and a putative
rescue mutation with isoleucine replacing glutamine at amino
acid 100.
Results
Most Informative Positive (MIP) active learning was designed to
find Positive examples, here p53 cancer rescue mutants, as quickly
as possible. Fourteen active learning methods (seven implemented
as MIP algorithms) and one random control were tested. The MIP
method Additive Curiosity performed best in silico, so was used to
select the Positive, Negative, and non-MIP regions. These regions
were assayed for novel p53 cancer rescue mutants.
This section contains:
(1) The in silico performance comparison of MIP and non-MIP
active learning algorithms.
(2) The regions selected by the regional selection algorithms.
(3) Novel rescue mutants discovered in the Positive, Negative,
and non-MIP regions.
(4) Other predicted p53 regions.
(5) 3D Visualizations of the putative rescue regions and
significant mutants.
Comparison of MIP and non-MIP Active Learning
Methods
For the purposes of this study, the best active learning method
was the method with the lowest Halfway Point, i.e., the method
that discovered half of the Positive mutants in the test set using the
smallest fraction of possible iterations. From Table 1, the best MIP
method reached the Halfway Point in 33% fewer iterations, and
the average MIP algorithm needed 28% fewer iterations, than
their non-MIP counterparts (p,0.006). Even the MIP versions of
the negative control methods, Maximum Marginal Hyperplane
and Minimum Entropy, performed better than any of the non-
MIP methods.
A graph showing the Halfway Point for select active learning
types with Data Partition 1, jTK,1j=25 and jTU,1j=236, is
presented in Figure 2.
Applying the MIP methodology improves how quickly a given
active learning algorithm uncovers the Positive mutants, but
what effect does it have on overall classifier accuracy? The 10-
fold cross-validated results, presented in Table 2 and Table 3,
show that MIP reduced the cross-validated accuracy by on
average 1.1% (statistically significant, p-Value=0.012) and the
correlation coefficient by on average 0.001 (not significant, p-
Value=0.755).
Positive, Negative, Non-MIP, and Expert Regions
The MIP Additive Curiosity algorithm performed best in
Tables 1, 2, and 3, and so was used to select three 10 amino acid
long regions as the Positive, Negative, and non-MIP Regions. The
Positive Region from residues 96–105 had the highest average
PositiveMean score (.938) and contained 351 mutants predicted to
be Positive out of 1900 total. The Negative Region from residues
223–232 had the highest average NegativeMean score (.937) and
contained 33 mutants predicted to be Positive. The non-MIP
Region from residues 222–231 had the highest Mean score (.938)
and contained 53 mutants predicted to be Positive. For
comparison, the Expert Region from residues 114–123 had a
Figure 1. Growth results at different yeast concentrations. Wild-
type refers to yeasts containing the wild-type p53 strain. Mutants
annotated with (S) are strong Positive cancer rescue mutants, (W) are
weak Positive cancer rescue mutants, and (N) are Negative mutants.
Different numbers of yeast cells expressing wild-type or mutant p53 as
indicated were spotted on growth media. The numbers of cells spotted
(from left to right) was 10,000, 2,000 and 400 cells. Cells were then
cultured at 37uC for 2 days and cell growth was assessed by the
observable increase in cells, which is proportional to the starting cell
number. Rescue mutants were designated as ‘‘strong’’ if they showed
better growth at the 2,000 cells per spot position than the cancer
mutant at 10,000 cells per spot. Rescue mutants were considered
‘‘weak’’ when growth advantage was only obvious when the 10,000
cells per spot were compared between rescue mutant and cancer
mutant.
doi:10.1371/journal.pcbi.1000498.g001
Table 1. Active learning halfway points.
Active Learning Type non-MIP MIP
Additive Curiosity 0.472 0.317
Maximum Curiosity 0.406 0.341
Minimum Marginal Hyperplane 0.423 0.356
Additive Bayesian Surprise 0.463 0.365
Maximum Entropy 0.461 0.388
Minimum Entropy 0.666 0.381
Maximum Marginal Hyperplane 0.639 0.403
Random (100 Trials) 0.502 +/20.084
The Halfway Points are averaged across the three data sets discussed in the
Methods section. Applying a paired Student’s t-test to these seven active
learning methods reveals a two-tailed p-value=0.011.
doi:10.1371/journal.pcbi.1000498.t001
Predicting Positive p53 Cancer Rescue Regions
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to be Positive. See Figure 3 for the scores across possible Positive
and Negative Regions and Figure 4 for a graph illustrating those
regions within the p53 core domain.
Regional Saturation Mutagenesis produced all possible single
amino acid mutations in these regions combined with the 10
common cancer mutants tested. A biological selection was
Figure 2. MIP versus non-MIP halfway points. Shown are the fraction of Positive mutants uncovered by MIP Maximum Curiosity and Additive
Curiosity compared with their non-MIP counterparts. The intersections with the dotted horizontal line correspond to the Halfway Point.
doi:10.1371/journal.pcbi.1000498.g002
Table 2. 10-fold cross-validated accuracy.
Active Learning Type non-MIP MIP
Additive Curiosity 73.4% 73.5%
Maximum Curiosity 72.9% 72.7%
Minimum Marginal Hyperplane 73.4% 72.1%
Additive Bayesian Surprise 74.7% 72.5%
Maximum Entropy 73.3% 72.1%
Minimum Entropy 73.4% 72.3%
Maximum Marginal Hyperplane 74.9% 73.1%
Average of seven methods above 73.7% 72.6%
Random (100 Trials) 72.4% +/24.36
The average 10-fold cross-validated accuracy for all training sets across the
three Data Partitions discussed in the Methods section. Applying a paired
Student’s t-test to these seven active learning methods reveals a two-tailed p-
value=0.012.
doi:10.1371/journal.pcbi.1000498.t002
Table 3. 10-fold cross-validated correlation coefficient.
Active Learning Type non-MIP MIP
Additive Curiosity .402 .423
Maximum Curiosity .390 .400
Minimum Marginal Hyperplane .404 .392
Additive Bayesian Surprise .428 .404
Maximum Entropy .393 .386
Minimum Entropy .370 .381
Maximum Marginal Hyperplane .409 .396
Average of seven methods above .399 .398
Random (100 Trials) .304 +/2.131
The average 10-fold cross-validated correlation coefficient for all training sets
across the three Data Partitions discussed in the Methods section. Applying a
paired Student’s t-test to these seven active learning methods reveals a two-
tailed p-value=0.755.
doi:10.1371/journal.pcbi.1000498.t003
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p53 cancer mutants in vivo.
The summary of these results is recorded in Table 4. The Positive
Region contained 8 strong and 3 weak mutants, the Expert Regions
contained 6 strong and 7 weak mutants, while the Negative and
non-MIP regions each contained only 2 weak mutants.
Table 4 also shows the p-values associated with the null
hypothesis ‘‘Positive mutants are equally likely to be drawn from
the Positive Region as the Negative, non-MIP, or Expert Region.’’
From this analysis we are at least 99.5% confident (one-tail) that
the Positive Region contains more strong cancer rescue mutants
than the Negative or non-MIP Region. Similarly, we infer that
there is no significant difference between the number of cancer
rescue mutants in the Positive and Expert regions.
Novel p53 Cancer Rescue Mutants
The novel p53 cancer rescue mutants found in the Positive,
Negative, and non-MIP regions are presented in Table 5 and
summarized in Table 6. Three different cancer mutants were
rescued by these regions: P152L, R158L and G245S. R158L was
rescued strongly by the Positive Region, and weakly by the
Negative and non-MIP regions. G245S was rescued weakly by the
Negative and non-MIP regions. P152L, a previously unrescued
cancer mutant, was rescued only by the Positive Region, and
rescued strongly.
Other Predicted p53 Regions
In addition to Additive Curiosity, six other (non-Random) active
learning methods were considered. Table 7 shows the Positive,
Negative, and non-MIP regions selected by those other methods.
The non-MIP region was similar to the Negative region due to the
preponderance of predicted Negative mutants in the test set.
Minimum Entropy and Maximum Marginal Hyperplane are
versions of Maximum Entropy and Minimum Marginal Hyper-
plane (repectively) designed to do poorly, as negative controls.
Indeed, the Negative Region chosen by Minimum Entropy
overlaps nine of ten residues with the Positive Region chosen by
Minimum Marginal Hyperplane. Similarly the Negative Region
chosen by Maximum Marginal Hyperplane overlaps eight of ten
residues with the Positive Region chosen by Maximum Entropy.
One might wonder if the classifier would have found the Expert
region as a Positive Region in future experiments. Figure 5
indicates the next Positive regions that would be selected, after the
mutants found in the current Positive, Negative, and non-MIP
regions, but not the Expert region, were added to the training set.
There, the most informative positive mutants were found in the
region from 130–156, but the region 103–119 also scored well,
overlapping the Expert Region (114–123). This is somewhat
surprising as the classifier does not consider the Expert criteria,
i.e., whether or not this residue appeared in a rescue mutant
previously.
Figure 3. Scores for Positive and Negative Regions using Additive Curiosity. The score at each residue is the average Additive Curiosity
score for the preceding ten residues. For example, the Positive Score at residue 105 scores the region from 96–105 to test if it is the best Positive
Region. The non-MIP Scores are omitted because they are nearly indistinguishable from the Negative Scores.
doi:10.1371/journal.pcbi.1000498.g003
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To better understand the regions selected and their relationship
to the p53 protein, it is helpful to consider molecular visualizations
of p53. Here, p53 is visualized with UCSF Chimera [33,42].
Figure 6 presents a visualization of the Positive, Negative, non-MIP,
and Expert regions on the p53core domain. It is noteworthy that all
of the regions selected in this study appear near the surface of the
p53 molecule even though that was not explicitly a criterion in their
selection. Figure 7 shows the surface residues selected by the mutual
information algorithm [36] to be significant in determining the
activity of p53 mutants [12]. Figure 8 shows all known single amino
acid rescue mutations. Figure 9 shows the 10 cancer mutants
presented in Table 6, Figure 10 including the newly rescued P152L.
Figure 10 shows a different visualization of Figure 7.
Discussion
This paper introduced Most Informative Positive (MIP) active
learning, based on machine learning techniques and modeled
structure-based features, to help guide biological experiments. The
method discovered novel and informative positive results.
Figure 4. Regional saturation mutagenesis scores and selections. Count indicates the number of mutants predicted to be Positive at each
residue in the p53 core domain and is represented as black dots corresponding to the leftmost y-axis. Average Curiosity Score is the average Additive
Curiosity score for the mutants predicted to be Positive at each residue and is represented as solid purple diamonds connected with lines and
corresponding to the rightmost y-axis. The solid green circles indicate contiguous regions of 10 or more residues that have high Curiosity and are
predicted to be Positive. The solid red squares indicate the contiguous regions of 10 or more residues that have high Curiosity and are predicted to
be Negative. The purple diamonds indicate contiguous regions that an expert might expect to contain rescue mutants based on previous
experiments. The light blue +s with the lines descending to the x-axis indicate the region explored in Baroni, et al., (2004), though this region is not
treated specially, nor is even known, by the classifier. The Positive, non-MIP, Negative, and Expert regions ultimately selected are presented above the
plot and labeled with P, n, N, and E respectively. No single amino acid rescue mutations had been found previously in any of the Positive, non-MIP,
Negative, or Expert regions.
doi:10.1371/journal.pcbi.1000498.g004
Table 4. Novel Positive cancer rescue mutant counts &
statistics.
Positive Negative non-MIP Expert
(96–105) (223–232) (222–231) (114–123)
# Strong 8 006
p-value - 0.008 0.008 0.791
# Weak 3227
p-value - 1.000 1.000 0.344
# Total 11 2 2 13
p-value - 0.022 0.022 0.839
The range of numbers listed below the region names are the amino acid
locations covered by that region. All p-values are two-tailed p-values; the
corresponding one-tailed values are half what is listed.
doi:10.1371/journal.pcbi.1000498.t004
Predicting Positive p53 Cancer Rescue Regions
PLoS Computational Biology | www.ploscompbiol.org 8 September 2009 | Volume 5 | Issue 9 | e1000498Medical Significance of the Data Set
The ten different cancer mutants studied here account for about
one million diagnosed cancers per year. The rescue of cancer
mutant P152L by a mutation in the Positive Region is the first
report that this common cancer mutant can be rescued at all.
The in silico identification and biological verification of a new
cancer rescue region is a small but hopefully useful step towards
selection of p53 surface regions that potentially result in p53
cancer rescue when appropriately modified. Such regions
eventually might be targeted by small molecule drugs. For
example, Figure 10 shows an area on the surface of the p53 core
domain that is: (1) away from the DNA binding region; (2)
overlapping or adjacent to the Positive Region; (3)implicated by
mutual information as influential in determining p53 activity;
and (4) located where structural changes restore functional
activity to some cancerous p53 mutants. Better knowledge of
p53 mutant structure-function relationships eventually might
lead to successful pharmaceutical manipulation of p53 mutant
function.
It has been hypothesized that different p53 cancer rescue
mutants have different rescue mechanisms corresponding to
different types of cancer mutations [22,25]. For example, the
Expert Region rescued the more frequent p53 cancer mutant
G245S while the Positive Region did not. Conversely, the Positive
Region is unique in its ability to rescue the P152L mutant.
Different rescue regions may implement different rescue mecha-
nisms, and so contribute different facets to knowledge of cancer
rescue.
Extensions
From Figure 4, the Expert Region had both low average
curiosity (.462) and relatively few (34) mutants predicted
Positive. Thus, this region was not selected by the classifier,
yet a significant number of rescue mutants were identified in
this region. This is not surprising, as the classifier was not
directly exposed to the criteria used for selecting the Expert
Region. Conversely, it is not surprising that an expert cancer
biologist could pick a fruitful region for reasons unknown to the
classifier. Adding expert-level knowledge to a performance
system is a long-time success story of artificial intelligence [43].
Integrating diverse expert sources and methods using bioinfor-
matics leads to biomedical discovery acceleration [44]. Adding
new features that encode expert or literature knowledge directly
into the feature vector that encodes each example is one simple
way to make expert knowledge visible to any feature-based
learning system.
Similarly, the classifier does not now weigh the medical impact
of different p53 cancer mutants. Cancer mutation occurrence
frequencies were not given to the classifier, so it is not surprising
that it rescued a less frequent cancer mutant than did the expert.
Weighting by cancer mutation frequency, or by any other desired
utility function, is one simple way to implement a selection
preference for some informative Positives over others.
Table 6. Novel Positive cancer rescue mutants by cancer
mutation.
Cancer Mutation Positive Negative Non-MIP
(96–105) (223–232) (222–231)
7: R249S 0 0 0
8: G245S 0 (1) (1)
14: H179R* 0 0 0
16: R273L 0 0 0
22: R248L 0 0 0
23: R158L 4 (1) (1)
26: R280T* 0 0 0
27: P151S* 0 0 0
32: P152L* 4+(3) 0 0
34: P278L* 0 0 0
Total 8+(3) 0+(2) 0+(2)
The number listed before the cancer mutant is the frequency rank of that
cancer mutant occurring in human cancer. e.g., R249S is the 7
th most frequent
single codon p53 mutation found in human cancer biopsies [12]. Weak Positive
cancer rescue mutant counts are in parentheses. Mutants marked with asterisks
had never been rescued at the beginning of this study.
doi:10.1371/journal.pcbi.1000498.t006
Table 7. Region selection by active learning algorithms.
Active Learning Type Positive Negative non-MIP
Additive Curiosity 96–105 223–232 222–231
Maximum Curiosity 100–109 222–231 222–231
Minimum Marginal Hyperplane 141–150 108–117 122–131
Additive Bayesian Surprise 96–105 222–231 222–231
Maximum Entropy 243–252 206–215 206–215
Minimum Entropy 170–179 140–149 140–149
Maximum Marginal Hyperplane 210–219 241–250 241–250
The range of numbers listed below the region names are the amino acid
locations covered by that region. Note that Minimum Entropy and Maximum
Marginal Hyperplane were control active learning methods designed to work
particularly poorly. More details are available in the supporting information
Table S1.
doi:10.1371/journal.pcbi.1000498.t007
Table 5. Novel Positive cancer rescue mutants by name.
Positive Region Negative/non-MIP Region Artifactual Mutants
P152L_q100i R158L_e224p (W) P152L_s106p
P152L_q100s G245S_t231y (W) P152L_l137m
P152L_q100t P152L_d207e
P152L_y103c R158L_l201p
R158L_q100f R158L_q100h_q104a
R158L_q100n R158L_q100a_q104r
R158L_q100s
R158L_q100t
P152L_q100a (W)
P152L_k101e (W)
P152L_k101n (W)
Mutants are named with the cancer mutation appearing first with capital letters
followed by the putative cancer rescue mutation(s) appearing after the
underscore. P152L means that the proline at the 152
nd amino acid location in
p53 is mutated into a leucine. The mutants appearing italicized with a (W), e.g.,
P152L_k101e, etc., are weak cancer rescue mutants. All others are strong cancer
rescue mutants. Artifactual Mutants are cancer rescue mutants that contained
more than one cancer rescue mutation or were not in any of the regions, due to
background mutagenesis and limitations in early versions of the saturation
mutagenesis technique.
doi:10.1371/journal.pcbi.1000498.t005
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PLoS Computational Biology | www.ploscompbiol.org 9 September 2009 | Volume 5 | Issue 9 | e1000498Figure 5. New scores for Positive Regions using new data from the non-expert regions. The score at each residue is the average Additive
Curiosity score for those mutants predicted to be Positive for the preceding ten residues. The classifier here was trained with the original 463 mutants
used in Figure 4, all Positive cancer rescue mutants found in the Positive, Negative, and non-MIP Regions, and all mutants from those three regions
that were not Positive labeled as Negative. The vertical lines show the original Expert Region from residues 114–123.
doi:10.1371/journal.pcbi.1000498.g005
Figure6.Thefourp53regionsvisualized withtheUCSFChimera
package. The blue atoms near the DNA are the Expert Region, the red
atoms near the top arethe Negativeandnon-MIPRegions, andthegreen
atoms near the bottom right are the Positive Region.
doi:10.1371/journal.pcbi.1000498.g006
Figure 7. Surface residues selected by mutual information. The
blue atoms are those on the p53 surface ranked in the top 50 by the
mutual information algorithm as influential on determining classifier
accuracy.
doi:10.1371/journal.pcbi.1000498.g007
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MIP active learning using modeled structural features was
introduced and shown to be a useful framework for func-
tion-based biological research. It provided an analysis tool
yielding results that otherwise would have been unexpected or
unavailable.
From the perspective of a biologist, the computer-selected
Positive Region would not have been chosen as a poten-
tial region for cancer rescue: It did not contain any known cancer
rescue mutants, and none of the random biology-based approach-
es had ever identified rescue activity in this region. This result
provides a proof-of-concept that a computational classifier and
modeled structure-based features can provide insight to help guide
function-based experimental discovery.
Availability
All code and data used in this paper is freely available online at
https://sourceforge.net/projects/p53cancerrescue/files/. The da-
ta is also available in Dataset S1.
All mutant DNA vectors are available under standard material
transfer agreements through the UCI Office of Technology
Alliances (http://www.ota.uci.edu/).
Supporting Information
Dataset S1 The raw curiosity scores used to generate Figures 3
& 5 and select the regions shown Table 7.
Found at: doi:10.1371/journal.pcbi.1000498.s001 (2.17 MB ZIP)
Table S1 Table 7 - Region Selection by Active Learning
Algorithms as dynamically generated by Microsoft Excel. Intended
for use with Dataset S1.
Found at: doi:10.1371/journal.pcbi.1000498.s002 (0.23 MB XLS)
Text S1 Active Learning Related Symbols
Found at: doi:10.1371/journal.pcbi.1000498.s003 (0.06MBDOC)
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Figure 8. Single cancer rescue mutations. The green atoms
clustered mostly in the center of p53 are single amino acid cancer
rescue mutations. The blue atoms, such as those on the left and
in the lower right corner, are those single cancer rescue muta-
tions that are also selected by mutual information as shown in
Figure 7.
doi:10.1371/journal.pcbi.1000498.g008
Figure 9. The ten p53 cancer mutants studied here. The red
atoms clustered primarily near the top left are those cancer
mutations that are currently unrescuable. The green atoms clustered
primarily near the lower left are the rescuable cancer mutations.
The yellow atoms near the right are the newly rescued P152
mutation.
doi:10.1371/journal.pcbi.1000498.g009
Figure 10. Rescue by p53 surface residues. The above visualiza-
tion is the same as Figure 9 but rotated and with the surface displayed.
doi:10.1371/journal.pcbi.1000498.g010
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